1. Home
  2. BNTC vs EVGO Comparison

BNTC vs EVGO Comparison

Compare BNTC & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • EVGO
  • Stock Information
  • Founded
  • BNTC 1995
  • EVGO 2010
  • Country
  • BNTC United States
  • EVGO United States
  • Employees
  • BNTC N/A
  • EVGO N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • EVGO Other Specialty Stores
  • Sector
  • BNTC Health Care
  • EVGO Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • EVGO Nasdaq
  • Market Cap
  • BNTC 352.5M
  • EVGO 376.5M
  • IPO Year
  • BNTC N/A
  • EVGO N/A
  • Fundamental
  • Price
  • BNTC $13.14
  • EVGO $3.74
  • Analyst Decision
  • BNTC Strong Buy
  • EVGO Strong Buy
  • Analyst Count
  • BNTC 7
  • EVGO 10
  • Target Price
  • BNTC $24.71
  • EVGO $5.78
  • AVG Volume (30 Days)
  • BNTC 34.4K
  • EVGO 4.1M
  • Earning Date
  • BNTC 05-23-2025
  • EVGO 05-06-2025
  • Dividend Yield
  • BNTC N/A
  • EVGO N/A
  • EPS Growth
  • BNTC N/A
  • EVGO N/A
  • EPS
  • BNTC N/A
  • EVGO N/A
  • Revenue
  • BNTC N/A
  • EVGO $276,954,000.00
  • Revenue This Year
  • BNTC N/A
  • EVGO $39.82
  • Revenue Next Year
  • BNTC N/A
  • EVGO $32.12
  • P/E Ratio
  • BNTC N/A
  • EVGO N/A
  • Revenue Growth
  • BNTC N/A
  • EVGO 45.15
  • 52 Week Low
  • BNTC $5.74
  • EVGO $1.78
  • 52 Week High
  • BNTC $16.90
  • EVGO $9.07
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 45.36
  • EVGO 72.81
  • Support Level
  • BNTC $13.35
  • EVGO $3.61
  • Resistance Level
  • BNTC $15.69
  • EVGO $4.17
  • Average True Range (ATR)
  • BNTC 0.77
  • EVGO 0.24
  • MACD
  • BNTC -0.08
  • EVGO 0.12
  • Stochastic Oscillator
  • BNTC 2.67
  • EVGO 74.16

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About EVGO EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

Share on Social Networks: